CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2025-06-05 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-02-08 | NELSEN ROBERT Director | Purchase | +363,637 | $5.50 | $2.0M | 10,667,387 |
| 2024-02-08 | NELSEN ROBERT Director | Purchase | +727,272 | $5.50 | $4.0M | 12,446,022 |
| 2024-02-08 | NELSEN ROBERT Director | Purchase | +727,272 | $5.50 | $4.0M | 12,446,022 |
| 2023-06-08 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-01-05 | NELSEN ROBERT Director | Grant or award | +536 | 1,353 | ||
| 2022-10-05 | NELSEN ROBERT Director | Grant or award | +321 | 817 | ||
| 2022-07-05 | NELSEN ROBERT Director | Grant or award | +266 | 496 | ||
| 2022-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-04-05 | NELSEN ROBERT Director | Grant or award | +230 | 230 | ||
| 2021-04-21 | NELSEN ROBERT Director | Other acquisition | +12,500 | 12,500 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion | +10,156,250 | 10,303,750 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion | +10,156,250 | 10,301,250 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion | +11,718,750 | 11,718,750 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion | +11,718,750 | 11,718,750 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion · Series A-1 Convertible Preferred Stock | −3,687,500 | 0 | ||
| 2021-02-08 | NELSEN ROBERT Director | Conversion · Series A-1 Convertible Preferred Stock | −3,687,500 | 0 |
Page 1 of 2 · 30 trades